Relative Strength Index (RSI)
|Bid||6.34 x 1000|
|Ask||9.50 x 800|
|Day's Range||7.30 - 7.83|
|52 Week Range||4.00 - 11.97|
|Beta (5Y Monthly)||1.26|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Piedmont Lithium Limited (ASX:PLL; NASDAQ:PLL) ("Piedmont" or "Company") is pleased to report the results of the Company’s pre-feasibility study ("PFS") for its proposed lithium hydroxide chemical plant ("Chemical Plant") in Kings Mountain, North Carolina, USA. The PFS assumes a stand-alone merchant Chemical Plant that would convert spodumene concentrate purchased on the global market to battery-grade lithium hydroxide ("Merchant Project").
Piedmont Lithium Limited (ASX:PLL; NASDAQ:PLL) ("Piedmont" or "Company") is pleased to announce that it has produced 120 kg of spodumene concentrate from core samples collected from the Company’s Piedmont Lithium Project ("Project") located within the world-class Carolina Tin-Spodumene Belt ("TSB") . These samples have now been used in the bench-scale lithium hydroxide testwork program nearing completion at SGS laboratories in Lakefield, Ontario. Concentrate qualities and recoveries were consistent with earlier testwork programs.
Piedmont Lithium Limited (ASX:PLL; NASDAQ:PLL) ("Piedmont" or "Company") is pleased to present its March 2020 quarterly report. Highlights during and subsequent to the quarter were: